Inventor
SPRIGGS MELANIE K
US33 patents
⚠️ This page may combine multiple inventors who share the name “SPRIGGS MELANIE K”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNEX CORP
32 patentsUS6087329AJul 11, 2000
CD40 ligand polypeptide
IMMUNEX CORP122 citations99
US6264951B1Jul 24, 2001
Methods of inhibiting CD40L binding to CD40 with soluble monomeric CD40L
IMMUNEX CORP86 citations97
US5962406AOct 5, 1999
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
IMMUNEX CORP96 citations97
US5869286AFeb 9, 1999
Receptor that binds IL-17
IMMUNEX CORP81 citations97
US5716805AFeb 10, 1998
Methods of preparing soluble, oligomeric proteins
IMMUNEX CORP145 citations97
US6680057B1Jan 20, 2004
Methods of treating autoimmune disease by administering interleukin-17 receptor
IMMUNEX CORP43 citations96
US6410711B1Jun 25, 2002
DNA encoding CD40 ligand, a cytokine that binds CD40
IMMUNEX CORP64 citations96
US6197525B1Mar 6, 2001
Assay kits for detection and methods of inhibiting IL-17 binding
IMMUNEX CORP46 citations96
US6191104B1Feb 20, 2001
Methods of treating graft rejection with the IL-17 receptor
IMMUNEX CORP41 citations96
US6100235AAug 8, 2000
Methods of treating immune and inflammatory response with IL-17 receptors
IMMUNEX CORP48 citations96
US6096305AAug 1, 2000
Receptor that binds IL-17
IMMUNEX CORP46 citations96
US6072033AJun 6, 2000
Receptor that binds IL-17
IMMUNEX CORP63 citations96
US6072037AJun 6, 2000
Antibodies to the IL-17 receptor
IMMUNEX CORP60 citations96
US5981724ANov 9, 1999
DNA encoding CD40 ligand, a cytokine that binds CD40
IMMUNEX CORP65 citations96
US5961974AOct 5, 1999
Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same
IMMUNEX CORP78 citations96
US5565321AOct 15, 1996
Detection of mutations in a CD40 ligand gene
IMMUNEX CORP56 citations96
US7405270B2Jul 29, 2008
CD40-Ligand lacking native-pattern glycosylation
IMMUNEX CORP32 citations92
US6290972B1Sep 18, 2001
Method of augmenting a vaccine response by administering CD40 ligand
IMMUNEX CORP26 citations92
US7432237B2Oct 7, 2008
Methods of treating asthma by administering interleukin-17 receptor
IMMUNEX CORP9 citations84
US7273843B2Sep 25, 2007
Methods of treating allergy by administering interleukin-17 receptor
IMMUNEX CORP7 citations74
US5716623AFeb 10, 1998
Isolated Herpesvirus saimiri proteins that bind MHC Class II molecules
IMMUNEX CORP11 citations74
US6106832AAug 22, 2000
Treatment of individuals exhibiting defective CD40L
IMMUNEX CORP12 citations72
US5925734AJul 20, 1999
Isolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchains
IMMUNEX CORP5 citations72
US5726286AMar 10, 1998
Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains
IMMUNEX CORP13 citations72
US7309489B1Dec 18, 2007
Mouse CD40 ligand-specific antibodies and hybridomas
IMMUNEX CORP1 citations63
US6670135B1Dec 30, 2003
Semaphorin polypeptides
IMMUNEX CORP2 citations63
US6187909B1Feb 13, 2001
Viral encoded semaphorin protein receptor polypeptides
IMMUNEX CORP2 citations62
US6174689B1Jan 16, 2001
Viral encoded semaphorin protein receptor DNA and polypeptides
IMMUNEX CORP3 citations62
US6130068AOct 10, 2000
Viral encoded semaphorin protein receptor DNA and polypeptides
IMMUNEX CORP3 citations62
US7214497B2May 8, 2007
Viral encoded semaphorin protein receptor DNA and polypeptides
IMMUNEX CORP0 citations51
US6562949B1May 13, 2003
Antibodies to viral encoded semaphorin protein receptor polypeptides
IMMUNEX CORP0 citations51
US6613320B1Sep 2, 2003
Defective CD4+T-cells that express active CD40-L
IMMUNEX CORP0 citations48